The Safe Quality Use of Medicines group have issued an alert regarding “Low Molecular Weight Heparin (LMWH) in Renal Impairment” Alert 5 (Primary Care Editions) November 2009.
Beth Loe, National co-ordinator of the DHBNZ Safe and Quality use of medicine group states “The Alert seeks to alert prescribers to the risk associated with prescribing LMWH in patients with imparied renal function and to provide guidelines for prescribers surrounding the management of these patients".
The medication alert can be found at www.safeuseofmedicines.co.nz Search alert 5